Therefore, rather than simply suppressing T-regs function, in the context of the tumor microenvironment PI3K inhibitors enhance or sustain activation of weakly activated CD8 positive cytotoxic T-cells, possibly through IL2 signaling. The gene discussed is IL2; the disease is neoplasm.